Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

HALOFANTRINE HYDROCHLORIDE CRS (125 MG)

HALOFANTRINE HYDROCHLORIDE CRS (125 MG)

36167-63-2

DISCOVER
HALOFANTRINE IMPURITY C CRS (10 MG)

HALOFANTRINE IMPURITY C CRS (10 MG)

38492-81-8

DISCOVER
HYDROXYCARBAMIDE CRS (360 MG)

HYDROXYCARBAMIDE CRS (360 MG)

127-07-1

DISCOVER
NAFTIDROFURYL IMPURITY A CRS (10 MG)

NAFTIDROFURYL IMPURITY A CRS (10 MG)

NA

DISCOVER
NAFTIDROFURYL IMPURITY B CRS (25 MG)

NAFTIDROFURYL IMPURITY B CRS (25 MG)

NA

DISCOVER
PIDOLIC ACID CRS (125 MG)

PIDOLIC ACID CRS (125 MG)

98-79-3

DISCOVER
PIDOLATE IMPURITY B CRS (110 MG)

PIDOLATE IMPURITY B CRS (110 MG)

NA

DISCOVER
GOSERELIN CRS (2 MG)

GOSERELIN CRS (2 MG)

65807-02-5

DISCOVER
Gosereline - reference spectrum, Qty : n/a

Gosereline - reference spectrum, Qty : n/a

NA

DISCOVER
ACEBUTOLOL IMPURITY C CRS (20MG)

ACEBUTOLOL IMPURITY C CRS (20MG)

40188-45-2

DISCOVER
ACEBUTOLOL IMPURITY I CRS (0.004 MG)

ACEBUTOLOL IMPURITY I CRS (0.004 MG)

NA

DISCOVER
AMIODARONE IMPURITY D CRS (20MG)

AMIODARONE IMPURITY D CRS (20MG)

NA

DISCOVER